mRNA |
pifithrin-alpha |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.03 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.03 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.03 |
mRNA |
AZ-3146 |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.03 |
mRNA |
GNF-2 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.03 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.03 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.03 |
mRNA |
PF-4800567 hydrochloride |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.03 |
mRNA |
TAE684 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.03 |
mRNA |
AZD0530 |
CCLE |
pan-cancer |
AAC |
-0.1 |
0.03 |